BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17996923)

  • 1. False incoagulable PT-INR results in oral anticoagulant therapy.
    Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
    Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample carryover in PT-INR determination is it an issue in Oral Anticoagulant Therapy control?
    Corno AR; Redaelli R; Caimi TM; Mostarda G; Caruso R; Morra E
    Thromb Res; 2011 Mar; 127(3):279-81. PubMed ID: 21129767
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
    Adcock DM; Johnston M
    Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?
    Jackson CM; Esnouf MP
    Clin Chem; 2005 Mar; 51(3):483-5. PubMed ID: 15738512
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
    Berkovsky A; Sergeeva EV; Suvorov AV; Uljavova IS; Kachalova ND; Klimovich LG; Samsonova NN; Kozlov AA
    Clin Chem Lab Med; 2006; 44(10):1214-7. PubMed ID: 17032133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The factors that influence the consistency of international normalized ratio of prothrombin time].
    Su W; Ren FQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):196-8. PubMed ID: 12905903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement of a new whole-blood PT/INR test using capillary samples with plasma INR determinations.
    Boehlen F; Reber G; de Moerloose P
    Thromb Res; 2005; 115(1-2):131-4. PubMed ID: 15567464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.
    Tripodi A; Caldwell SH; Hoffman M; Trotter JF; Sanyal AJ
    Aliment Pharmacol Ther; 2007 Jul; 26(2):141-8. PubMed ID: 17593061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
    Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
    Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical derivative applied to international normalised ratio and analytical variations in oral anticoagulant therapy control.
    Introcaso G; Cuboni A; Ratto A; Foieni F
    Haemostasis; 2000; 30(6):281-9. PubMed ID: 11356996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 17. The INR: a perspective.
    Smith RE
    Semin Thromb Hemost; 1997; 23(6):547-9. PubMed ID: 9469628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of the INR: how good is your laboratory's INR and can it be improved?
    Favaloro EJ; Adcock DM
    Semin Thromb Hemost; 2008 Oct; 34(7):593-603. PubMed ID: 19085760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Quick and Owren prothrombin time methods for oral anticoagulant therapy do not agree well using the International Normalized Ratio (INR) units.
    Horsti J
    Scand J Clin Lab Invest; 2003; 63(6):455-6. PubMed ID: 14594327
    [No Abstract]   [Full Text] [Related]  

  • 20. The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.
    van den Besselaar AM
    J Int Fed Clin Chem; 1991 Sep; 3(4):146-53. PubMed ID: 20821873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.